Union Korea Pharm Co., Ltd. (KOSDAQ:080720)
South Korea · Delayed Price · Currency is KRW 8,175.00
-930.00 (-10.21%)
At close: Oct 11, 2024
Union Korea Pharm Market Cap
Union Korea Pharm has a market cap or net worth of 19.7 billion as of October 23, 2026. It is the 38,902nd most valuable company in the world and the 2,426th biggest in South Korea. Its market cap has decreased by 43.69% in one year.
Market Cap
19.70B
Enterprise Value
51.10B
Revenue
25.45B
Global Rank
Country Rank
#2,426 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since July 26, 2018, Union Korea Pharm's market cap has decreased from 112.03B to 19.70B, a decrease of -82.41%. That is a compound annual growth rate of -24.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 11, 2024 | 19.70B | -44.88% |
| Dec 28, 2023 | 35.74B | -30.77% |
| Dec 29, 2022 | 51.63B | -33.98% |
| Dec 30, 2021 | 78.19B | -46.23% |
| Dec 30, 2020 | 145.43B | 77.22% |
| Dec 30, 2019 | 82.06B | 7.80% |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Korea Arlico Pharm | 32.65B |
| HLscience | 28.16B |
| Pharmsville | 26.70B |
| Baskhanbio Pharma | 25.27B |
| Seoul Pharma | 22.19B |
| BIFIDO | 21.68B |
| Daesung Microbiological Labs. | 21.55B |
| WooGene B&G | 18.51B |